MORNING UPDATE: Man Securities Inc. issues alerts for TWX, ERES, NUE, LIN, and BMC

MORNING UPDATE: Man Securities Inc. issues alerts for TWX, ERES,
NUE, LIN, and BMC 


CHICAGO, March 14  /PRNewswire/ -- Man Securities issues the following Morning
Update at 8:30 AM EST with new PriceWatch Alerts for key stocks.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20020214/MANSECLOGO )

Before the open... PriceWatch Alerts for TWX, ERES, NUE, LIN, and BMC, Market
Overview, Today's Economic Calendar, and the Quote Of The Day.

QUOTE OF THE DAY

"In general, rising interest rates are not necessarily a bad thing for the
market if they reflect a strengthening economy, but if they reflect higher
inflation, then that could present a problem for the stock market." -- Michael
Sheldon, chief market strategist, Spencer Clarke.

  New PriceWatch Alerts for TWX, ERES, NUE, LIN, and BMC...

  PRICEWATCH ALERTS - HIGH RETURN COVERED CALL OPTIONS -----------
  -- Time Warner Inc. (NYSE:TWX)
  Last Price 17.50 - JUL 17.00 CALL OPTION@ $1.20 -> 4.3 % Return assigned*
  -- Eresearchtechnology Inc. (NASDAQ:ERES)
  Last Price 11.53 - JUN 10.00 CALL OPTION@ $2.15 -> 6.6 % Return assigned*
  -- Nucor Corp. (NYSE:NUE)
  Last Price 62.55 - JUL 55.00 CALL OPTION@ $10.30 -> 5.3 % Return assigned*
  -- Linens N Things Inc. (NYSE:LIN)
  Last Price 22.65 - JUL 22.50 CALL OPTION@ $1.80 -> 7.9 % Return assigned*
  -- BMC Software Inc. (NYSE:BMC)
  Last Price 15.83 - AUG 15.00 CALL OPTION@ $1.80 -> 6.9 % Return assigned*




* To learn more about how to use these alerts and for our FREE report, "The 18
Warning Signs That Tell You When To Dump A Stock ", go to:
http://www.investorsobserver.com/mu18

(Note: You may need to copy the link above into your browser then press the
[ENTER] key)

** For the FREE report, "Is Your Investment Portfolio Disaster Proof? -
Insights, Stocks, And Strategies." go to:
http://www.investorsobserver.com/FREEDP

NOTE: All stocks and options shown are examples only.  These are not
recommendations to buy or sell any security.

NEWS LEADERS AND LAGGARDS

So far today, Endo Pharmaceuticals, International Business Machines, and
Ascential Software lead the list of companies with the most news stories while
OfficeMax and Genworth Financial are showing a spike in news. The Walt Disney
Co., Marriott International, and Cemex SA de CV have the highest srtIndex
scores to top the list of companies with positive news while American
International Group and Alcatel lead the list of companies with negative news
reports. AutoZone has popped up with a high positive news sraIndex score.

For the FREE article titled, "Earnings Season Decoded - An Essential 15 Point
Checklist For Finding Winning Stocks." go to:
http://www.wallstreetsecretsplus.com/go/freemu/

MARKET OVERVIEW

Overseas markets are looking strong, as 12 of the 15 that we track are
currently higher with the cumulative average return standing at plus 0.140
percent.  The Japanese government surprised investors by revising its Gross
Domestic Product (GDP) data for the October-December period.  After the
revision, Japan's GDP showed slight expansion instead of a slight narrowing.
The new GDP grew 0.1 percent from the July-September quarter.  Japan's economy
grew at an annualized expansion of 0.5 percent, the earlier report showed a 0.5
percent decline.  The surprising revision up was attributed to revisions in
inventories and government consumption.  This revised data still indicates that
Japan was in a technical recession for half of 2004.

The April contract on sweet crude oil fell $1.23 a barrel, a 2.3-percent drop
in trading on Friday.  This morning, crude oil has continued its decline,
dipping 30 cents to $54.13 a barrel.

Be prepared for the investing week ahead with Bernie Schaeffer's FREE Monday
Morning Outlook.  For more details and to sign up, go to:
http://www.investorsobserver.com/freemo

DYNAMIC MARKET OPPORTUNITIES

With a 7% increase in 2004, global drug sales experienced the slowest year for
growth since 1998. In total, sales hit US$550 billion, with a massive 45%
coming from North America. The news comes as drug/biotech companies endure a
fierce amount of additional pressure from the Food & Drug Administration
following several high-profile drug catastrophes such as Merck's painkiller
Vioxx and Biogen and Elan's multiple sclerosis drug Tysabri. In addition, a
shortage of new drugs on the market is hurting profit margins at some
companies. Unsurprisingly, China boasts the fastest-growing drug market, with
sales soaring 28% last year to US$9.5 billion. The data comes courtesy of IMS
Health, which goes on to note that China will enjoy the fastest growth rate for
the next four years, with the compound annual figure reaching 13%-16%. That's
significantly higher than the rest of the world, which will muster up 6% to 9%
drug sales growth. The world's biggest-selling drug in 2004 was Pfizer's
cholesterol drug Lipitor, which posted global sales of US$12 billion last year.
Merck's cholesterol drug Zocor finished second, with US$5.9 billion in sales,
while Bristol-Myers Squibb's anti-clotting product Plavix ended third, with
sales of US$5 billion. While drug sales slowed, one area that experienced solid
growth was advertising spending. The U.S. presidential and Summer Olympics
contributed to spending rising almost 10% in 2004 - the best year since 2000 -
as the total amount spent hit US$141.1 billion. TNS Media Intelligence reports
that of 17 subsectors, 16 enjoyed increases last year, with only national spot
radio ads seeing a decline. Online ad spending was the biggest gainer, with a
20% spike. By company, General Motors boosted its advertising with a massive
17.5% increase to US$2.8 billion. But Proctor & Gamble took the honors for
greatest amount spent with a 7.4% rise to US$2.9 billion.

Receive incisive economic/market commentary, profitable advice and access to a
network of leading investment exports. Simply follow this link:
http://www.investorsobserver.com/agora2

  TODAY'S ECONOMIC CALENDAR
  No major economic news today.




Actively track stocks with Quote.com's QCharts and get the real time quotes and
streaming technical charts you need to keep up with the market. For your free
30-day trial go to: http://www.investorsobserver.com/MUQuote1

Man Securities Inc. is one of the world's leading option order execution firms.
Man's in-house broker team offers a level of personal service and experience
unavailable from no-frills discount brokers. To improve your understanding of
option pricing get Man's FREE "Margin/Option Wizard software at:
http://www.investorsobserver.com/mancd. Member CBOE/NASD/SPIC.   CRD# 6731

This Morning Update was prepared with data and information provided by:

InvestorsObserver.com - Better Strategies for Making Money -> For Investors
With a Sense of Humor.  Only $1 for your first month plus seven free bonuses
worth over $420, see:  http://www.investorsobserver.com/must

Quote.com QCharts-  Real time quotes and streaming technical charts to keep you
up with the market.  Analyze, predict, and stay ahead. for a Free 30 day trial
go to: http://www.investorsobserver.com/MUQuote2

247profits.com:  You'll get exclusive financial commentary, access to a global
network of experts and undiscovered stock alerts. Register NOW for the FREE
247profits e-Dispatch. Go to:  http://www.investorsobserver.com/agora

Schaeffer's Investment Research  - Sign up for your FREE e-weekly, Monday
Morning Outlook, Bernie Schaeffer's look ahead at the markets. Sign Up Now
http://www.investorsobserver.com/freemo

PowerOptionsPlus - The Best Way To Find, Compare, Analyze, and Make Money On
Options Investments. For a 14-Day FREE trial and 5 FREE bonuses go to:
http://www.investorsobserver.com/poweropt

All stocks and options shown are examples only.  These are not recommendations
to buy or sell any security and they do not represent in any way a positive or
negative outlook for any security.  Potential returns do not take into account
your trade size, brokerage commissions or taxes which will affect actual
investment returns. Stocks and options involve risk and are not suitable for
all investors and investing in options carries substantial risk. Prior to
buying or selling options, a person must receive a copy of Characteristics and
Risks of Standardized Options available from Sharon at 800-837-6212 or at
http://www.cboe.com/Resources/Intro.asp. Privacy policy available upon request.


http://www.newscom.com/cgi-bin/prnh/20020214/MANSECLOGO

http://photoarchive.ap.org/

DATASOURCE: Man Securities



CONTACT:  John Gannon of Man Securities Inc., [phone]



Web site:  http://www.mansecurities.com/mu.html 

Copyright